EP0217206A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Medicament against chronic graft-versus-host diseases, as well as against autoimmune diseases, particularly systemic lupus erythematodes
Assignee: Sanofi Aventis Deutschland GmbH
•
Filing: 1986-09-13
•
Granted: —
•
Expires: 2006-09-13
Abstract
Abstract Translated from German Verwendung der Verbindung 1 und/oder 2 der Formeln bzw. von Salzen der Verbindung 2 zur Herstellung von Arzneimitteln gegen chronische Graft-versus-Host-Krankheiten sowie gegen Autoimmunerkrankungen, insbesondere systemischen Lupus erythematodes, sowie Dosierungseinheit der Arzneimittel. Use of compound 1 and / or 2 of the formulas or of salts of compound 2 for the production of medicaments for chronic graft-versus-host diseases and for autoimmune diseases, in particular systemic lupus erythematosus, and dosage unit of the medicaments.
Inventors
- 👤 Robert R. Dr. Bartlett
- 👤 Rudolf Dr. Schleyerbach
- 👤 Friedrich-Johannes Dr. Kämmerer
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-07 22:10
CPC Classifications
C; C07; C07C; C07C255/00; C07C255/01; C07C255/23; A; A61; A61K; A61K31/00; A61K31/275; A61K31/33; A61K31/395; A61K31/41; A61K31/42; A61P; A61P37/00; A61P37/02; A61P37/04; A61P37/06
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.